Summary
This prediction ended on 01.11.22 with a price of €16.86. The SELL prediction by BiotechBee finished with a performance of 11.64%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| GSK plc | 2.490% | 2.490% | 22.886% | 38.972% |
| iShares Core DAX® | -1,86 % | 0,67 % | 0,92 % | 51,85 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % | 33,72 % | 86,85 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % | 52,96 % | 63,32 % |
| iShares S&P 500 | -1,31 % | 3,40 % | 24,67 % | 66,11 % |
According to BiotechBee what are the pros and cons of GSK plc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread GlaxoSmithKline plc diskutieren
Sell mit Kursziel 10,0